Epidemiological study, immunohistochemistry and in situ hybridization studies of nasopharyngeal carcinomas: A Tunisian report

Pathologie Biologie

Volumn 57, Issue 5, 2009, Pages 427-429

  Hila, L ^a   Farah, F ^b   Ayari, H ^b   Ferjaoui, M ^b   Dehria, W ^b   Ben Jilani, S ^b  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Encoded nuclear antigen (EBNA1); Epidemiology; Epstein Barr virus encoded small RNA1 (EBER1); Latent membrane proteins (LMP1); Nasopharyngeal carcinomas (NPC)

Indexed keywords

ALCOHOL; CELL NUCLEUS ANTIGEN; IMMEDIATE EARLY PROTEIN BZLF1; LATENT MEMBRANE PROTEIN 1; PROTEIN EBER1; PROTEIN EBNA1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NASOPHARYNX CARCINOMA; SEX RATIO; TUNISIA; VIRUS GENOME; WATER QUALITY;

BIOPSY; CARCINOMA; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; RNA, VIRAL; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUNISIA; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS LATENCY;

EID: 67649380882     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.07.029     Document Type: Article

References (11)

1. Bashir R., Luka J., Cheloha K., Chamberlain M., and Hochberg F. Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology 43 (1993) 2358-2362
2. Bing Luo, Yun W., Xiao-Feng W., Hua L., Li-Ping Y., Bao-HuaH, et al. Expression of Epstein Barr virus genes in EBV-associated gastric carcinomas. Gastric Cancer 11 5 (2005) 629-633
3. Ben Abdallah M. Épidémiologie des cancers en Tunisie, 1996. Registre de l'institut Salah-Azaiz-ATCC-I.M.P., STAG-Tunis.
4. Busson P., Ooka T., and Corbex M. Carcinomes nasopharyngés associés au virus d'Epstein-Barr : de l'épidémiologie à la thérapeutique et au dépistage. Med Sci (Paris) 20 (2004) 453-457
5. Gharbi MK, Gritli S, Boussen H. Epidemiologic features of 1869 cases of nasopharyngeal carcinoma (NPC) seen in the Salah Azaiz Insitute from 1969 to 1987. Proceedings ASCO; 1996. Abstract No. 431.
6. Gulley M.L., Glaser S.L., and Craig F.E. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin's disease. Am J Clin Pathol 117 (2002) 259-267
7. Martel-Renoir D., Grunewald V., Touitou R., Schwaab G., and Joab I. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol 76 (1995) 1401-1408
8. Mokni-Baizig N., Boussen H., Kharrat A., Ben Ayed F., Ladgham Bel Haj O., and El May H. In situ hybridization in undifferenciated nasopharynx carcinoma in Tunisia. Report of 3 cases. Tunis Med 79 10 (2001) 544-547
9. Spano J.P., Busson P., Atlan D., Bourhis J., Pignon J.P., Esteban C., et al. Nasopharyngeal carcinomas: an update. Eur J Cancer 39 (2003) 2121-2135
10. Tedeschi R., Pin E., Martorelli D., Bidoli E., Marus A., Pratesi C., et al. Epstein -Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 64 (2004) 3407-3416
11. Young L.S., and Rickinson A.B. Epstein Barr virus: 40 years on. Cancer 4 (2004) 757-768